Belmont
Belmont
Belmont, Massachusetts, United States60 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Novel and Conventional Interventions for Cognitive and Emotional Flexibility in Patient Trauma | anxiety, anxiety disorder, depressive disorder, psychiatric disorder | Active, not recruiting | Phase 2 | 2026-10-09 | NCT07868627 | |
| Digital Coach to Support Exposure Therapy Homework for Anxious Youth | anxiety disorder, obsessive-compulsive personality disorder, psychiatric disorder | Not yet recruiting | Not applicable | 2026-10-07 | NCT07666672 | |
| A Study of Brenipatide in Adult Participants With Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Recruiting | Phase 2 | 2026-10-07 | NCT07410507 | |
| A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 3 | 2026-10-06 | NCT03887455 | |
| Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis | Digestive System Diseases, Feeding and Eating Disorders, Psychotic Disorders, Rumination Syndrome, Schizophrenia Spectrum and Other Psychotic Disorders, anxiety, anxiety disorder, depressive disorder, digestive system disorder, psychiatric disorder, rumination disorder | Not yet recruiting | Not applicable | 2026-10-05 | NCT07503093 | |
| Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD) | Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 2 | 2026-10-01 | NCT04464980 | |
| Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) | Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Recruiting | Not stated | 2026-09-30 | NCT07101094 | |
| Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, endometriosis, female reproductive system disorder | Active, not recruiting | Phase 2 | 2026-09-30 | NCT06477406 | |
| PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Active, not recruiting | Phase 2 | 2026-09-30 | NCT03984565 | |
| Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) | Psychosis Associated With Alzheimer's Disease | Recruiting | Phase 3 | 2026-09-29 | NCT05980949 | |
| A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial | Depressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-25 | NCT07227103 | |
| Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101 | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Not yet recruiting | Early phase 1 | 2026-09-22 | NCT07785102 | |
| A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) | Alzheimer disease, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 3 | 2026-09-22 | NCT06585787 | |
| Recovery Inspired Support Engagement (RISE) Pilot | Chemically-Induced Disorders, Substance Use Disorders, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-09-15 | NCT07519759 | |
| One-Day cTBS Over the Precuneus | Depressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorder | Recruiting | Not applicable | 2026-09-11 | NCT07758010 | |
| MDMA-AT for PTSD in Young Adults With Childhood Trauma | Stress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorder | Not yet recruiting | Phase 2 | 2026-08-20 | NCT07765693 | |
| Cerebellar Modulation of Cognition in Psychosis | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizoaffective disorder, schizophrenia | Recruiting | Not applicable | 2026-08-20 | NCT06107764 | |
| EEG and Actigraphy Biomarkers of Written Exposure Therapy for Posttraumatic Stress Disorder | Stress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorder | Not yet recruiting | Not applicable | 2026-08-17 | NCT07766798 | |
| Open Label Extension Study of NCT06221852 | Bipolar and Related Disorders, Insulin Resistance, Nutritional and Metabolic Diseases, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, bipolar disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, mood disorder, psychiatric disorder, schizoaffective disorder | Enrolling by invitation | Not applicable | 2026-08-17 | NCT06558201 | |
| Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder | Bipolar and Related Disorders, Insulin Resistance, Nutritional and Metabolic Diseases, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, bipolar disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, mood disorder, psychiatric disorder, schizoaffective disorder | Recruiting | Not applicable | 2026-08-17 | NCT06221852 | |
| Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-14 | NCT07593222 | |
| Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD | Depressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-08-10 | NCT05711940 | |
| A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder | Personality Disorders, borderline personality disorder, psychiatric disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-05 | NCT07460947 | |
| Biomarkers to Enhance Early Schizophrenia Treatment | Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Recruiting | Phase 4 | 2026-07-31 | NCT06969755 | |
| Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Pelvic Infection, Urogenital Diseases, adenomyosis, endometriosis, female reproductive system disorder, pelvic inflammatory disease, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2026-07-27 | NCT07728695 |